Influence of proteinuria on cardiovascular risk and response to angiotensin-converting enzyme inhibition after myocardial infarction.

To the Editor: Proteinuria is a known predictor of cardiovascular (CV) morbidity and mortality in diabetics, hypertensive patients, and the general population ([1–3][1]), but the impact of proteinuria as a risk factor after acute myocardial infarction (MI) is less well-defined. We analyzed a